Date: Monday 30^th October 2017

Time: 2-3.30pm UK / 3-4.30pm CET / 9-10.30am EST

In this webinar, the EU regulatory and Industry members of the ICH E9(R1) working group will present the new draft addendum for ICH E9 on estimands and sensitivity analysis. The addendum introduces a new framework for designing and analysing clinical trials aligned to the trial objectives.

Rob Hemmings (MHRA) will present the motivation behind the new draft addendum, define estimands and sensitivity analysis, and explain different strategies that can be used in constructing an estimand.

Frank Bretz (Novartis) will present case studies to illustrate how the new framework can be implemented in designing clinical trials and defining the appropriate analysis methods. A Q&A session will be chaired by Frank Pétavy(EMA) and Chrissie Fletcher (Amgen).

This webinar is free to attend. Click here to register, and then you will receive details to log into the webinar. It is recommended that individuals within a company/institution attend the webinar together where possible. Thanks to PSI for hosting the webinar

To download the event flyer please Click Here